Since cholecystokinins (CCK8) seems to be the physiological ligand of CCK receptors in the brain,
The peptide cholecystokinin (CCK) exists in multiple molecular forms both in endocrine cells of the gut and in peripheral and central neurons (Larsson and Rehfeld, 1978, 1979; Rehfeld et al., 1979; Dockray, 1982; Morley, 1982; Emson and Marley, 1983) . In the gut, where CCKs, CCK:sA, and presumably CCKr2 are the predominant fragments (Mutt and Jorpes, 1968; Dockray, 1977; Rehfeld, 1978; Brand and Morgan, 1981; Rehfeld et al., 1982) , CCK stimulates gall bladder contraction and the secretion from the exocrine pancreas, acting as a gastrointestinal hormone (Jorpes and Mutt, 1973; Case, 1978) .
Pancreatic islet cells, at least in some species, are innervated by CCK neurons containing mainly CCK4 (Larsson, 1979; Rehfeld et al., 1980) . CCK, potently stimulates the release of hormones from the endocrine pancreas (Rehfeld et al., 1980) .
In the central nervous system, CCK-like immunoreactivity was demonstrated in neuronal perikarya and processes in particular in the cerebral cortex and parts of the limbic system (Straus et al., 1977; Innis et al., 1979; Loren et al., 1979; Schneider et al., 1979; Emson et al., 1980a; Barden et al., 1981; Beinfeld et al., 1981; Beinfeld and Palkovits, 1981; Dockray et al., 1981) . The main CCK fragment present in nerve terminal fractions was CCKs (Pinget et al., 1978; Emson et al., 1980b) . It was released upon K'-induced depolarization of synaptosomes and brain slices (Pinget et al., 1979; Dodd et al., 1980; Emson et al., 1980b ). Thus, CCKH, which is also present in human brain (Perry et al., 1981) , appears to be the CCK fragment released physiologically from central CCK neurons, suggesting a role for CCK, as a neurotransmitter or neuromodulator. Application of CCKR, CCK7, or CCK, to neurons resulted in a marked excitatory response (Oomura et al., 1978; Dodd and Kelly, 1981; Jeftinija et al., 1981; Skirboll et al., 1981) or in inhibition of neuronal firing (CCK,; Morin et al., 1983) . Pharmacologically, CCKB effects include anticonvulsant (Zetler, 1980b) , antinociceptive (Zetler, 1980a; Basso et al., 1981; Jurna and Zetler, 1981) , and feeding suppressant activity (Della-Fera and Baile, 1979; Stacher et al., 1979; Smith et al., 1981) .
CCK receptors in brain and pancreas were investigated previously in biochemical and autoradiographical radioligand binding studies. However, the radioligands used were strongly modified CCK peptides. In most studies (Sankaran et al., 1980; Hays et al., 1980 Hays et al., , 1981 Innis and Snyder, 1980a; Saito et al., 1980,198l; Zarbin et al., 1981 Zarbin et al., , 1983 , CCKs3 was conjugated with ['""IlBolton-Hunterreagent (['""IIBH; Bolton and Hunter, 1973) , an Nterminus peptide modification which appeared to be justified since [""I]BH-CCK:13 retained biological activity in the exocrine pancreas (Sankaran et al., 1979) . However, it is unknown whether the compound is active in the endocrine pancreas and in the brain. Furthermore, although the biological activity of CCK resides in the Cterminal part of the peptide, modification at the Nterminus of CCKcj3 can affect the interaction with CCK receptor sites. Thus, saturable binding sites could only be detected with '""I-monoiodo-labeled BH-CCKrr3 but not with ""I-diiodo-labeled BH-CCKI13 in brain and pancreas (Innis and Snyder, 1980a) . In addition, the binding characteristics of ["'I] BH-CCK,, may not be representative for the receptor interaction of small CCK fragments such as CCK,; possible CCK receptors with high affinity for CCKR but lack of affinity for CCKzz would remain unnoticed with [1251] BH-CCK,, as radioligand. Similarly, [1251] desaminotyrosy1-CCKs (Miller et al., 1981) , [3H] pentagastrin (Gaudreau et al., 1983) , and [ lz51] imidoester-CCKs (Praissman et al., 1983) , which were also used as radioligands in binding studies, are greatly modified CCK derivatives.
Since CCK, seems to be the physiological ligand of CCK receptors in the brain, the most suitable radioligand for CCK receptor studies in the CNS is the "H-labeled CCK,. Although ["H]CCK8 was prepared earlier, its specific activity was too low for receptor binding studies (Milutinovic et al., 1977; Morgat et al., 1977) . Therefore, in the present study, ['H]CCK8 was prepared with a specific activity sufficient to detect high affinity binding sites. It is the first study to describe the biochemical characteristics and autoradiographical localization of CCK receptor sites in brain and pancreas using ["HI CCKB as radioligand. A preliminary communication of our results was published previously (van Dijk et al., 1981) .
Materials and Methods
Peptides. All CCK peptides used were sulfated on tyrosine 27 and amidated at the C-terminal end, unless stated otherwise. The following compounds were synthetized according to Gillessen et al. (1979) : CCKH, desulfated CCKB, CCKa acid, the methoxinine-analogues [Mox"] -, [Mox"] -, and [Mox",~]-CCK~, in which the possible oxidation of the sulfur atom of the methionine residues in position 3 and/or 6 is prevented by replacing methionine by methoxinine (a-amino-y-methoxybutyric acid), all smaller CCK fragments, the gastrin-I peptides, arginine-vasotocin, lysine-vasopressin, delta sleep-inducing peptide, thyrotropin-releasing hormone, luteinizing hormone-releasing hormone, and secretin. CCKsz was a generous gift from Dr. V. Mutt, Karolinska Institute, Stockholm. Caerulein was kindly provided by Farmitalia Carlo Erba, Milano. Pentagastrin was purchased from Bachem Feinchemikalien AG, Switzerland, motilin and vasoactive intestinal peptide from Peninsula Laboratory, and all remaining peptides from Beckman Bioproducts.
Preparation of [3H1CC&. Desulfated CCKs was labeled with 3H in the phenyl ring of tyrosine and subsequently sulfated with pyridine-SO3 (D. Gillessen, manuscript in preparation). Purified [3H]CCKs (specific activity: 33 Ci/mmol) was stored in liquid nitrogen, and an aliquot was repurified once a week by high pressure liquid chromatography (HPLC) (Spherisorb ODS column 250 x 5 mm; eluent:acetonitril/O.O.!Y M NH40Ac, pH 4.0 (27:73, v/v)). More than 95% of the label eluted in the same position as nonradioactive CCKs as judged by liquid scintillation counting and ultraviolet absorption at 225 nm in two eluent systems (methanol/O.06 M KP04 buffer, pH 7.7 (45:55) and the above-mentioned eluent).
Tissue preparation. Brain tissue from male SPF rats (150 gm) was homogenized in 20 vol of ice-cold 0.32 M sucrose, centrifuged at 1000 X g for 10 min, followed by recentrifugation of the supernatant at 140,000 x g for 45 min (P2 + P3 pellet). The pellet was resuspended in 20 vol of HEPES buffer (10 mM HEPES, 130 mM NaCl, 5 mM MgClz adjusted with NaOH to pH 7.4), centrifuged for 10 min at 48,000 x g, and used immediately or stored at -20°C. Pancreatic membrane fractions were prepared according to Innis and Snyder (1980a) . The tissue was homogenized in 20 vol of ice-cold HEPES buffer and centrifuged at 48,000 x g for 10 min. After resuspension in the same volume and recentrifugation, the pellet was resuspended in 180 vol of HEPES buffer and used immediately.
Binding assays. Frozen brain membranes were used throughout apart from specifically indicated experiments with fresh membranes. Membrane pellets were suspended in 20 vol of HEPES buffer, centrifuged at 48,000 x g for 10 min, and resuspended in 7.5 v01 of HEPES buffer. Aliquots containing about 3.5 mg of protein were incubated for 20 min at 22°C in a final volume of 2 ml of HEPES buffer containing bacitracin (0.02% w/v), phenylmethansulfonylfluoride (PMSF; 1 pg/ml), 130 mM NaCl, and 0.2 nM ["H]CCKR. Specific binding was defined as the difference between the amount of ["H]CCKs bound in the absence (total binding) and in the presence (nonspecific binding) of 1 PM CCK,. The incubation was terminated by filtration through Whatman GF/B filters, which were washed twice with 3 ml of ice-cold HEPES buffer. After shaking the filters in Aquasol-for 1 hr at room temperature, the radioactivity was counted. In the experiments on the nucleotide dependency of [3H]CCKR binding, the stability of GTP, ATP, GMP, AMP, ADP, and GDP was tested by applying an aliquot of the supernatant, recovered after completion of the assay, on cellulose thin layer chromatography plates (Merck 5552; solvent system isobutyric acid/l M ammonia/0.1 M EDTA in H, O; 50:30:0.8; v/v) . Comparison of the UV fluorescent spots with reference compounds indicated no degradation of nucleotides apart from a 50% loss of ATP.
Association and dissociation rate constants were calculated according to Bennett (1978) .
Autoradiography. Slide-mounted lo-pm frontal cryostat sections of fresh brain and pancreas were labeled in vitro according to Young and Kuhar (1979) by incubation for 20 min at 22°C with hM [3H]CCKH in HEPES buffer containing bacitracin (0.02%) and PMSF (1 pg/ml), followed by three 15-set washes in the HEPES buffer and a final dip in distilled water at 4°C. The washing (three X 15 set) reduced the amount of specific binding on the sections by about 20% compared to a single dip in water. Alternating sections were incubated with [3H]CCKs in the presence of 0.5 pM caerulein and 0.05 pM CCK, for pancreas and brain, respectively. After incubation, the sections were dried at 4°C under a stream of ice-cold nitrogen, apposed to emulsion (Ilford K5)-coated coverslips, and then exposed for 6 to 7 weeks at 4°C. Autoradiograms were evaluated with a Zeiss photomicroscope III using darkfield optics. Semiquantitative analyses of grain densities in various brain regions were performed on projected negatives at a final magnification of x 640.
Protein determination. Protein was determined according to the method of Lowry et al. (1951) .
Results
General characteristics of 13H]CCK8 binding. The amount of total and nonspecific binding of [3H] CCKs to the membrane fractions was 1600 and 400 dpm/assay for cerebral cortex and 12,000 and 200 dpm/assay for pancreas, respectively (Fig. 1, A and B) . Specific binding of [3H]CCKs showed a linear protein dependency up to 4.0 mg/assay for cerebral cortex and 0.4 mg/assay for pancreas. Incubations were performed at 22°C because specific binding at 0°C was three and 10 times lower in brain and pancreas, respectively. Bovine serum albumin (BSA, 0.2% w/v) was added to the assay medium only when CCK33 and caerulein were present in order to prevent their adsorption to the wall of the test tubes. BSA had no influence on the amount of specific binding of [3H] CCKs or on the displacing potency of nonradioactive CCKs.
The radioligand did not appear to be metabolized under the assay conditions used. After incubating [3H] CCKs (1 nM) with membranes from cerebral cortex or pancreas for 20 and 120 min, respectively, 93 to 95% of and 160 min for pancreatic membranes, respectively. The apparent dissociation constants (I&,) calculated from the ratio of the dissociation and association rate constants k-l/k+l were 5.8 and 0.1 nM in the cortex and 0.33 and 0.03 nM in pancreas, respectively.
Saturation of [3H]CCK8 specific binding sites. Specific binding of [3H]CCKs in various brain areas and in pancreas was saturable with increasing concentrations of the radioligand (Fig. 2) . The apparent dissociation constants were rather similar throughout the brain, while the maximum number of binding sites (B,,,) differed markedly in various brain areas (Table I) . High values were found in olfactory bulb, striatum, and cerebral cortex, followed by hypothalamus, hippocampus, midbrain, and medulla pons, without detectable specific binding in cerebellum. In pancreas, the Ko value was somewhat lower than in the brain; the maximum number of binding sites, however, exceeded the highest value in the brain by a factor of 40 (Table I ). According to the criteria of Scatchard plot linearity, only one population of specific binding sites was apparent in all brain areas tested and in pancreas.
Ligand specificity of [3HJCCK, binding sites. Displacement of [3H]CCK8 from its binding sites was achieved only with peptides structurally related to CCK (Fig. 3 , Table II ). Caerulein, CCKs, and CCK,, revealed highest displacing potencies in both cerebral cortex and pancreas.
The Mox-derivatives of CCKB displayed marked potencies, with a rank order similar for both tissues. Desulfated CCKR was devoid of displacing potency in the pancreas, but it was only 16 times less potent than CCKs in the cortex. Also, the gastrin-I peptides, being unsulfated, showed no displacement in the pancreas but considerable potency in the cortex (Table II) . Of the smaller CCK peptides tested, CCK, was active in the cortex but not in the pancreas. This differential affinity was also found for the CCK, derivatives pentagastrin and [NLeu']-CCK, (Table II) . The presence of the C-terminal amido group in CCKlike peptides appeared to be essential for binding affinity, since the acids of CCK, and CCKs were devoid of displacing capacity in both cerebral cortex and pancreas (Table II) .
A variety of drugs and peptides chemically unrelated to CCK failed to inhibit ["H]CCK, binding in brain and pancreas (see legend to Table II ["H]CCK8 in the absence and presence of 0.5 PM CCK, (brain) and 0.5 Z.LM caerulein (pancreas), washed and dried as described under "Materials and Methods." The amount of radioactivity bound to the tissue was determined by scintillation counting after scraping the tissue off the slide. van Dijk et al. Vol. 4, No. 4, Apr. 1984 sl, nucleus septi lateralis; sn, substantia nigra; SR, sulcus rhinalis; st, nucleus interstitialis striae terminalis; t, thalamus. served in the olfactory bulb, sulcus rhinalis, olfactory tubercle, nucleus accumbens, hypothalamus, dentate gyrus, amygdala, and layers III and IV of the cerebral cortex (Fig. 6 ). Cortical labeling was most pronounced in cingular ( Fig. 6A) and occipital (Fig. 7A) regions, but it was also marked in frontal (Fig. 6E) , pyriform, and entorhinal cortex. In the olfactory bulb, dense labeling was observed in the external plexiform layer and to a lesser extent in the glomerular layer (Fig. 6C) . High density labeling was detected in the olfactory tubercle, but only background levels were present in the olfactory tract (Fig. 6D ). Whereas labeling in the nucleus accumbens was higher than in the neostriatum, only background levels were observed in the septum (Fig. 6F ). In the hippocampal area only the hilus (polymorphic region) of the dentate gyrus and its caudal ventrolateral extension were markedly labeled (Table IV) . Appreciable labeling was found in the locus ceruleus. A rather low amount of labeling was found in the substantia nigra and even less in the molecular layer of the cerebellum (Fig. 7B , Table  IV ). Specific accumulation of radioactivity in cell bodies was never observed in the brain regions examined. The distribution of [3H]CCK8 specific binding sites in the brain areas studied is summarized schematically in Figure 5 . Nonspecific labeling of [3H]CCKe in the presence of CCK, was similar to the background levels in gray as well as in white matter as illustrated for the cingular cortex (Fig. 6B) .
Pancreas. The pancreas was the most intensely labeled tissue compared to all brain areas studied (Fig. 7C , Table  IV ). The labeling was equally distributed over the endocrine and exocrine pancreas. Caerulein, but not CCK4, was able to prevent this labeling (Fig. 70) .
Discussion
Since CCK8 is the CCK fragment released from central neurons, it is the most suitable probe for the identification of CCK receptors in radioligand binding studies. We have prepared ['3H]CCK8 as a new probe with a specific radioactivity suitable for high affinity binding studies. The biochemical characteristics and autoradiographical distribution of the ["H]CCK8 specific binding sites identified in brain and pancreas are in line with the concept that they represent CCK receptors. In the following, the ligand specificity, regional distribution, and autoradiographical localization of the ["H]CCKs binding sites in brain and pancreas are discussed, followed by a comparison of the characteristics of the sites identified by ["HI CCK, or other CCK radioligands in brain and pancreas.
[:'H]CCK8 specific binding sites in rut brain Ligand specificity. The saturable specific binding sites for ["H]CCK8 were highly specific for CCK-like peptides. Caerulein and CCK:j:I, which have seven and eight amino acids, respectively, in common with CCKH, were the most potent displacing agents besides CCKs itself (Fig. 3 , Table II ). Desulfated CCK, was 16 times less potent than CCKR. CCK, and all gastrin-I peptides which share the last five C-terminal amino acids with CCK, displayed considerable potency, whereas a wide variety of other peptides and nonpeptidergic compounds were completely inactive in inhibiting ["H]CCK8 binding (Table II) This ligand specificity of the ["H]CCKR specific binding sites compares well with the electrophysiological activity of CCK peptides. CCKR, CCK7, and CCK, produce a marked excitatory response of neurons in various brain areas (Oomura et al., 1978; Dodd and Kelly, 1981; Jeftinija et al., 1981; Skirboll et al., 1981) . A discrepancy exists only for nonsulfated CCK,; although a potent displacer of ["H]CCK8 binding in rat cerebral cortex (Table II) , it was found to leave neuronal activity unaltered in rat hippocampal slices (Dodd and Kelly, 1981) .
Regional distribution. Saturation of the ['H]CCK8 binding sites revealed rather similar dissociation constants for CCK8 in different brain regions (Table I) . Although only one population of binding sites was suggested using the criterion of Scatchard plot linearity in all brain areas tested, the biphasic dissociation of CCKH in cerebral cortex may indicate a heterogeneity of central CCK binding sites (Fig. 1A) .
The density of the ["H]CCK, specific binding sites varied considerably in different brain regions (Table I) . Their rank order largely corresponded to that of CCKlike immunoreactivity. Notably, both cerebral cortex and olfactory bulb showed high amounts of ["H]CCK, specific binding (Table I ) and contain CCK-like immunoreactivity (Schneider et al., 1979; Beinfeld et al., 1981; Dockray et al., 1981) .
The cerebellum contained no appreciable amount of either [3H]CCK, specific binding sites (Table I) or CCKlike immunoreactivity (Schneider et al., 1979; Beinfeld et al., 1981; Dockray et al., 1981) , underlining the physiological significance of the binding sites identified by ["H]CCKs. Autoradiogruphical uisualization.
["H]CCKR specific binding sites were found widely distributed throughout the CNS with enrichment in cortical and limbic areas. Highest densities of ["H]CCKe binding sites were observed throughout the cortex (notably layers III and IV), olfactory tubercle, nucleus accumbens, olfactory bulb, sulcus rhinalis, and amygdala with no appreciable binding in cerebellum (Figs. 5 to 7) . This pattern corresponded largely to the distribution of CCK-like immunoreactivity. Immunohistochemically, in rat neocortex, CCKR terminals are found in all parts of the cortex (Emson and Hunt, 1981; Hendry et al., 1983) . In addition, dense fluorescent fibers have been located in the sulcus rhinalis, central nuclei of the amygdala, and dorsomedial and ventromedial hypothalamus but not in the cerebellum (Innis et al., 1979; Larsson and Rehfeld, 1979; Hijkfelt et al., 1980a; Vandephaeghen et al., 1980) . Furthermore, thin fibers, but no positively stained cell bodies, were detected in the olfactory tubercle and nucleus accumbens (Vanderhaeghen et al., 1980) . The hippocampus and dentate gyrus contain a moderate number of immunoreactive CCK terminals (Emson et al., 1980b; Handelmann et al., 1981) . Our study revealed consistently higher ["H]CCK, binding in the hilus of the dentate gyrus than in the hippocampus. Electrophysiologically, a strong excitatory response was found after application of CCK, to hippocampal CA, pyramidal cells (Dodd and Kelly, 1981) .
It has been reported that dopamine and CCK coexist in a subpopulation of dopaminergic neurons in the A,/ A,, region (HGkfelt et al., 1980b; Studler et al., 1981) . Although the immunoreactivity is mainly in cell bodies in this area (Hijkfelt et al., 1980a; Vanderhaeghen et al., 1980) , there is also evidence for CCK terminals (Williams et al., 1981) . Iontophoretic application of CCK7 induced bursting patterns of Alo neurons in which CCK-like immunoreactivity was present (Skirboll et al., 1981) . We found only a moderate amount of [3H]CCKs labeling in the Ag but no labeling in the Alo region, indicating a receptor density in the Alo region below the detection limit of our assay. In general, however, there was a marked parallelism between the distribution of [3H] CCKs labeling and CCK-like immunoreactive material. This evidence, taken together with the ligand specificity of the [3H]CCK8 specific binding sites, supports their role as CCK receptors.
[3H]CCK8 specific binding sites in rat pancreas Saturable high affinity binding sites for [3H]CCKs were also found in pancreas. Caerulein, CCKR and CCKS13 were the most potent displacing agents, whereas CCK4, in striking contrast to the binding sites in the brain, was virtually inactive in displacing ["H]CCKR (Table II) . Furthermore, deamination of CCKR (CCK, acid) and desulfation (desulfated CCK, and gastrin-I series) both dramatically reduced the displacing potency in comparison to CCKs (Table II) . Thus, the entire CCKR sequence appears to be required for a high affinity binding in van Dijk et al. Vol. 4, No. 4, Apr. 1984 pancreas. The ligand specificity of the binding sites in pancreas corresponded to their biological activity. CCKs, caerulein, and CCKs3, but not CCK4, are potent stimulators of pancreatic exocrine secretion (Rehfeld et al., 1980; Jensen et al., 1981) . Furthermore, the displacing potency of the Mox-derivatives in ["H]CCKB binding in pancreas correlates with their biological response (Gillessen et al., 1979) . Thus, the [3H]CCK, specific binding sites may represent the pancreatic target sites for the action of CCK as a gastrointestinal hormone. CCK, (but not CCK,, and CCK,) is very potent in stimulating hormone secretion from pancreatic islet cells as shown in pig and man (Rehfeld et al., 1980) . These cells are innervated in several species (pig, cat, hamster) by CCK neurons containing mainly CCK, (Larsson, 1970; Rehfeld et al., 1980) . Thus, receptors for CCK, would be expected to be present in the endocrine pancreas. However, in the rat, the species used in this study, there is no indication of an interaction of CCK, with islet cell function. Likewise, a pancreatic innervation by CCK neurons is unknown. Correspondingly, CCK, lacked inhibitory potency in ["H]CCKR binding in pancreas (Table II) . Autoradiographically, the uniform labelling of ["H]CCKR throughout the pancreas could be displaced by caerulein (Fig. 7 , C and D) but in no part by CCK,. Hence, within the detection limit of this assay, our results suggest that the islets of Langerhans in the rat are not under the control of CCK,.
[3H]CCK8 specific binding in pancreas, but not in cerebral cortex, was inhibited by several guanyl nucleotides (Table III) . The pattern of specificity was similar to that of the other neurotransmitter and hormone receptors that are regulated by guanyl nucleotides and linked to an adenylate cyclase. Thus, CCK receptors in pancreas, but not in brain, may be linked to an adenylate cyclase.
Comparison of binding sites labeled by [3H]CCK8 or other CCK radioligands
Previously, [1251]BH-CCK33 was used in an attempt to characterize CCK receptors in the brain of the rat (Hays et al., 1980; Saito et al., 1980; Zarbin et al., 1983) , mouse (Saito et al., 1981) , and guinea pig (Innis and Snyder, 1980a; Zarbin et al., 1981 Zarbin et al., , 1983 . Furthermore, ["HIpentagastrin (Gaudreau et al., 1981) and ['2'I]imidoester-CCKR (Praissman, 1983) were used in rat brain. CCK binding sites in the pancreas were previously characterized by ['2'I]BH-CCK,3 binding in the rat (Sankaran et al., 1979; Innis and Snyder, 1980b; Steigerwaldt and Williams, 1981) and guinea pig (Jensen et al., 1980) . In addition, ['2'I]desaminotyrosy1-CCK8 was used with rat pancreas (Miller et al., 1981) . In the following, these studies are compared to our results obtained in rat brain and pancreas with ['H]CCK, as radioligand.
Brain. The characteristics of ["H]CCK8 specific binding resemble those obtained with [""IIBH-CCK,, with regard to the K. value, Scatchard plot linearity, and rank order of inhibitory potencies of CCK peptides (Innis and Snyder, 1980a; Saito et al., 1980) . However, our findings are at variance with those of Hays et al. (1980) , who found no difference in displacing potency between CCKssulfated CCKs-unsulfated, CCK33, and caerulein in [1251] BH-CCKB3 binding in rat brain. A further difference in displacing potency exists for sulfated and nonsulfated CCK8. These peptides can be differentiated by their displacing potencies in binding assays with ["H]CCKR (Table II) , ['251]BH-CCK33 (Innis and Snyder, 1980a; Saito et al., 1980; Saito et al., 1981) (Table III) . Furthermore, while both ['H]CCK8 and ['2"I]BH-CCK33 binding were enhanced by divalent cations to a similar degree (Fig. 4; Innis and Snyder, 1980a; Saito et al., 1981) , they differed considerably in their sensitivity to monovalent cations. In the presence of NaCl, LiCl, or KC1 (60 mM),
[3H]CCKs specific binding remained unaltered in either frozen or fresh rat cerebral cortex, whereas [12"I]BH-CCK33 binding in guinea pig brain (Innis and Snyder, 1980a ) and mouse brain (Saito et al., 1981) was reduced by 50%. Although a species difference between rat (this study), guinea pig (Innis and Snyder, 1980a) , and mouse brain (Saito et al., 1981 ) cannot be excluded, it is conceivable that ['*"I]BHCCKx3 interacts with a larger domain of the CCK receptor protein than [3H]CCK,, including sites sensitive to guanyl nucleotides and monovalent cations. However, these nucleotide and cation recognition sites are probably not relevant for the regulation of the ligand binding reaction physiologically inasmuch as the binding of the physiological ligand CCK, is not regulated by guanyl nucleotides or monovalent cations. Alternatively, it is also feasible that the two radioligands label, at least in part, subtypes of CCK sites with different regulatory characteristics.
Some indications for a possible heterogeneity of CCK binding sites are given by the dissociation rates of the radioligands. A biphasic dissociation curve was found for [3H]CCKs in rat brain (Fig. 1A) and for [1251]BH-CCK33 in mouse brain (Saito et al., 1980) . However, a monophasic dissociation was observed for ['2"I]BH-CCK,3 in rat and guinea pig brain (Hays et al., 1980; Innis and Snyder, 1980a) .
Autoradiographically, the labeling pattern for ["HI CCKa (rat brain) was similar to that of ['251]BH-CCKX3 (guinea pig brain; Zarbin et al., 1981 Zarbin et al., , 1983 , notably for the laminar distribution in cerebral cortex. However, the cerebellum, interpeduncular nucleus, olfactory tract, optic tract, parts of the hippocampus, and layer VI of cerebral cortex were strongly labeled by ['251 ]BH-CCK33 (Zarbin et al., 1981 (Zarbin et al., , 1983 
